Age-dependent Neurofibrillary Tangle Formation, Neuron Loss, and Memory Impairment in a Mouse Model of Human Tauopathy (P301L)

Overview

Journal J Neurosci

Specialty Neurology

Date 2005 Nov 18

PMID 16291936

Citations 367

Authors

Martin Ramsden

Linda Kotilinek

Colleen Forster

Jennifer Paulson

Eileen McGowan

Karen SantaCruz

Aaron Guimaraes

Mei Yue

Jada Lewis

George Carlson

Michael Hutton

Karen H Ashe

Affiliations

Soon will be listed here.

Abstract

Here, we describe the generation of a novel transgenic mouse model of human tauopathy. The rTg(tau(P301L))4510 mouse expresses the P301L mutation in tau (4R0N) associated with frontotemporal dementia and parkinsonism linked to chromosome 17. Transgene expression was driven by a forebrain-specific Ca(2+) calmodulin kinase II promoter system resulting in high levels of expression in the hippocampus and neocortex. Importantly, transgene expression in this model is induced via the tetracycline-operon responsive element and is suppressed after treatment with doxycycline. Continued transgene expression in rTg(tau(P301L))4510 mice results in age-dependent development of many salient characteristics of hereditary human dementia. From an early age, immunohistochemical studies demonstrated abnormal biochemical processing of tau and the presence of pathological conformation- and phosphorylation-dependent epitopes. Neurofibrillary tangle (NFT) pathology was first observed in the neocortex and progressed into the hippocampus and limbic structures with increasing age. Consistent with the formation of NFTs, immunoblots indicated an age-dependent transition of accumulating tau species from Sarkosyl soluble 55 kDa to insoluble hyperphosphorylated 64 kDa. Ultrastructural analysis revealed the presence of straight tau filaments. Furthermore, the effects of tau(P301L) expression on spatial reference memory were longitudinally tested using the Morris water maze. Compared with nontransgenic age-matched control littermates, rTg(tau(P301L))4510 mice developed significant cognitive impairments from 4 months of age. Memory deficits were accompanied by gross forebrain atrophy and a prominent loss of neurons, most strikingly in hippocampal subdivision CA1. Collectively, these data describe a novel transgenic mouse that closely mimics human tauopathy and may represent an important model for the future study of tau-related neurodegenerative disease.

Citing Articles

Antagonizing Il10 and Il4 signaling via intracerebral decoy receptor expression attenuates Aβ accumulation.

Koller E, McFarland K, Angelle C, Howard J, Ryu D, Dillon K Acta Neuropathol Commun. 2025; 13(1):51.

PMID: 40055831 PMC: 11887169. DOI: 10.1186/s40478-025-01968-3.

Reduction of Neuroinflammation as a Common Mechanism of Action of Anorexigenic and Orexigenic Peptide Analogues in the Triple Transgenic Mouse Model of Alzheimer´s Disease.

Mengr A, Smotkova Z, Pacesova A, Zelezna B, Kunes J, Maletinska L J Neuroimmune Pharmacol. 2025; 20(1):18.

PMID: 39932627 PMC: 11813825. DOI: 10.1007/s11481-025-10174-w.

Paradoxical attenuation of early amyloid-induced cognitive impairment and synaptic plasticity in an aged APP/Tau bigenic rat model.

Emmerson J, Do Carmo S, Lavagna A, Huang C, Wong T, Martinez-Trujillo J Acta Neuropathol Commun. 2024; 12(1):193.

PMID: 39707506 PMC: 11662582. DOI: 10.1186/s40478-024-01901-0.

Animal models of Alzheimer's disease: Current strategies and new directions.

Wang Q, Zhu B, Lei P Zool Res. 2024; 45(6):1385-1407.

PMID: 39572020 PMC: 11668949. DOI: 10.24272/j.issn.2095-8137.2024.274.

Arc mediates intercellular tau transmission via extracellular vesicles.

Tyagi M, Chadha R, de Hoog E, Sullivan K, Walker A, Northrop A bioRxiv. 2024; .

PMID: 39484489 PMC: 11526995. DOI: 10.1101/2024.10.22.619703.

References

Weingarten M, Lockwood A, Hwo S, Kirschner M . A protein factor essential for microtubule assembly. Proc Natl Acad Sci U S A. 1975; 72(5):1858-62. PMC: 432646. DOI: 10.1073/pnas.72.5.1858. View

Spittaels K, Van den Haute C, Van Dorpe J, Bruynseels K, Vandezande K, Laenen I . Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am J Pathol. 1999; 155(6):2153-65. PMC: 1866931. DOI: 10.1016/S0002-9440(10)65533-2. View

Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, van Slegtenhorst M . Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet. 2000; 25(4):402-5. DOI: 10.1038/78078. View

Buee L, Bussiere T, Delacourte A, Hof P . Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev. 2000; 33(1):95-130. DOI: 10.1016/s0165-0173(00)00019-9. View

Lewis J, Dickson D, Lin W, Chisholm L, Corral A, Jones G . Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. 2001; 293(5534):1487-91. DOI: 10.1126/science.1058189. View

Wolfer D, Madani R, Valenti P, Lipp H . Extended analysis of path data from mutant mice using the public domain software Wintrack. Physiol Behav. 2001; 73(5):745-53. DOI: 10.1016/s0031-9384(01)00531-5. View

Westerman M, Mariash A, Kotilinek L, Kawarabayashi T, Younkin L, Carlson G . The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci. 2002; 22(5):1858-67. PMC: 6758862. View

Hardy J, Selkoe D . The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002; 297(5580):353-6. DOI: 10.1126/science.1072994. View

Urbanc B, Cruz L, Le R, Sanders J, Ashe K, Duff K . Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease. Proc Natl Acad Sci U S A. 2002; 99(22):13990-5. PMC: 137824. DOI: 10.1073/pnas.222433299. View

10.

Allen B, Ingram E, Takao M, Smith M, Jakes R, Virdee K . Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J Neurosci. 2002; 22(21):9340-51. PMC: 6758022. View

11.

Sun L, Liu S, Zhou X, Wang X, Liu R, Wang Q . Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats. Neuroscience. 2003; 118(4):1175-82. DOI: 10.1016/s0306-4522(02)00697-8. View

12.

Andorfer C, Kress Y, Espinoza M, de Silva R, Tucker K, Barde Y . Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J Neurochem. 2003; 86(3):582-90. DOI: 10.1046/j.1471-4159.2003.01879.x. View

13.

Gossen M, Bujard H . Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A. 1992; 89(12):5547-51. PMC: 49329. DOI: 10.1073/pnas.89.12.5547. View

14.

Cruz J, Tseng H, Goldman J, Shih H, Tsai L . Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron. 2003; 40(3):471-83. DOI: 10.1016/s0896-6273(03)00627-5. View

15.

Liu S, Zhang A, Li H, Wang Q, Deng H, Netzer W . Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory. J Neurochem. 2004; 87(6):1333-44. DOI: 10.1046/j.1471-4159.2003.02070.x. View

16.

Janus C . Search strategies used by APP transgenic mice during navigation in the Morris water maze. Learn Mem. 2004; 11(3):337-46. PMC: 419737. DOI: 10.1101/lm.70104. View

17.

Terwel D, Lasrado R, Snauwaert J, Vandeweert E, Van Haesendonck C, Borghgraef P . Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice. J Biol Chem. 2004; 280(5):3963-73. DOI: 10.1074/jbc.M409876200. View

18.

Iqbal K, Alonso A, Chen S, Chohan M, El-Akkad E, Gong C . Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta. 2004; 1739(2-3):198-210. DOI: 10.1016/j.bbadis.2004.09.008. View

19.

Sun L, Wang X, Liu S, Wang Q, Wang J, Bennecib M . Bilateral injection of isoproterenol into hippocampus induces Alzheimer-like hyperphosphorylation of tau and spatial memory deficit in rat. FEBS Lett. 2004; 579(1):251-8. DOI: 10.1016/j.febslet.2004.11.083. View

20.

Ikeda M, Shoji M, Kawarai T, Kawarabayashi T, Matsubara E, Murakami T . Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice. Am J Pathol. 2005; 166(2):521-31. PMC: 1602315. DOI: 10.1016/S0002-9440(10)62274-2. View